Liposomes, marvels in biopharmaceutics, are microscopic vesicles composed of lipid bilayers. These versatile structures hold immense promise in drug delivery, encapsulating pharmaceutical agents within their lipid layers. The liposome's unique ability to mimic cell membranes enables targeted drug delivery, enhancing therapeutic efficacy while minimizing side effects.
In the realm of biopharmaceutics, liposomes serve as ingenious carriers for both hydrophobic and hydrophilic drugs, offering a controlled and sustained release. Their biocompatibility and customizable surface properties facilitate interaction with specific cell types, allowing for precision in therapeutic interventions. This has profound implications for treating various diseases, including cancer, infections, and inflammatory disorders.
The flexibility of liposomes extends to their adaptability for incorporating imaging agents, making them invaluable tools in diagnostics. As biopharmaceutics continues to evolve, liposomes stand at the forefront, ushering in a new era of targeted and personalized medicine, poised to revolutionize the landscape of drug delivery and therapeutic interventions.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia